ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $660,000,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,080,113 | $50,301,000 | 4.98% |
| Foresite Capital Management II, LLC | 188,602 | $8,783,000 | 3.96% |
| Artal Group S.A. | 1,650,000 | $76,841,000 | 3.14% |
| Foresite Capital Management III, LLC | 254,923 | $11,872,000 | 3.09% |
| Asymmetry Capital Management, L.P. | 30,125 | $1,403,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,255,174 | $58,453,000 | 2.24% |
| QVT Financial LP | 190,977 | $8,894,000 | 2.24% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $12,546,000 | 1.51% |
| Novo Holdings A/S | 198,261 | $9,233,000 | 1.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,375,000 | $110,604,000 | 0.83% |